Metagenomi Therapeutics Statistics
NASDAQ: MGXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
0.9847-0.0453 (-4.40%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Metagenomi Therapeutics by the numbers
Metagenomi Therapeutics has a market capitalization of $37.2 million based on 37.78M shares outstanding. With trailing EPS of $-2.49, Metagenomi Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.7% below its 50-day average and 28.0% below its 200-day average.
Average daily trading volume is 155.71K shares, or about $153,330 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MGX valuation vs. peer median
| Metric | MGX | Peer median | Difference |
|---|---|---|---|
| Market cap | $37.20M | $36.93M | +1% |
| Avg. volume | 155.71K | 105.92K | +47% |
Peer median across 8 companies: CVM, GNTA, ELUT, ALGS, TVGN, BSEM, EVAX, TIL.
Valuation
- Market cap
- $37.20M
- EPS (TTM)
- $-2.49
- Shares outstanding
- 37.78M
Price and trading
- Previous close
- 1.03
- Open
- 1.01
- Day range
- 0.96 – 1.02
- 52-week range
- 0.96 – 3.95
- 52-week change
- -66.62%
- Beta
- —
- Volume
- 269.82K
- Average volume
- 155.71K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 13, 2025
Additional statistics
- Market Cap
- 37.20M
- Forward Pe
- -0.54
- Eps
- -2.49
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.95
- Week52 Low
- 0.96
- Avg Volume
- 155.71K
- Shares Outstanding
- 37.78M
- Ma50
- 1.17
- Ma200
- 1.37
- Earnings Date
- Aug 13, 2025
- Pct From52w High
- -75.07%
- Pct From52w Low
- 2.57%